EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential

Anna De Bartolo, Naomi Romeo, Tommaso Angelone iD, Carmine Rocca iD

Acta Physiologica · 2025-07 · 241 (7)

DOI: 10.1111/apha.70062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Physiologica, online erschienen am 28.05.2025. Verfasst von Anna De Bartolo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Cardiovascular Physiology and Pathophysiology Laboratory, Department of Biology, E. And E. S. (DiBEST), University of Calabria…. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Inflammation, Inflammation Mediators, Cardiotonic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bando PRIN 2022, codice identificativo 2022AA37N3, The Next Generation EU - project Tech4You - Technologies for climate change adaptation and quality of life improvement, n. ECS0000009, co-funding from Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8-Project Age-It: "Ageing Well in an Ageing Socie….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Timely myocardial reperfusion is essential for restoring blood flow to post‐ischemic tissue, thereby reducing cardiac injury and limiting infarct size. However, this process can paradoxically result in additional, irreversible myocardial damage, known as myocardial ischemia–reperfusion injury (MIRI). The goal of this review is to explore the role of specialized pro‐resolving mediators (SPMs) in atherosclerosis and MIRI, and to assess the therapeutic potential of targeting inflammation resolution in these cardiovascular conditions.

Methods

This review summarizes current preclinical and clinical evidence on the involvement of SPMs in the pathogenesis of atherosclerosis and MIRI, acknowledging that several cellular and molecular aspects of their mechanisms of action remain to be fully elucidated.

Results

MIRI is a complex phenomenon in which inflammation, initially triggered during ischemia and further amplified upon reperfusion, plays a central role in its pathogenesis. Various cellular and molecular players mediate the initial pro‐inflammatory response and the subsequent anti‐inflammatory reparative phase following acute myocardial infarction (AMI), contributing both to ischemia‐ and reperfusion‐induced damage as well as to the healing process. SPMs have emerged as key endogenous immunoresolvents with potent anti‐inflammatory, antioxidant, and pro‐resolving properties that contribute to limit excessive acute inflammation and promote tissue repair. While dysregulated SPM‐related signaling has been linked to various cardiovascular diseases (CVD), their precise role in AMI and MIRI remains incompletely understood.

Conclusion

Targeting inflammation resolution may represent a promising therapeutic strategy for mitigating atheroprogression and addressing a complex condition such as MIRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryInflammationInflammation MediatorsCardiotonic AgentsHumansAnimalsAtherosclerosisMyocardial InfarctionSpecialized Pro-Resolving Mediators

Stichwörter der Autor:innen

cardioprotectioninflammationmyocardial ischemia/reperfusionpro‐resolving mediatorssignal transduction cardiac function

Substanzen

Inflammation MediatorsCardiotonic Agents

Autor:innen und Institutionen

  • Cellular and Molecular Cardiovascular Physiology and Pathophysiology Laboratory, Department of Biology, E. And E. S. (DiBEST), University of Calabria, Cosenza, Italy.
  • National Institute of Cardiovascular Research (INRC), Bologna, Italy.

ORCID-Profile: Tommaso Angelone, Carmine Rocca

Förderung

  • Bando PRIN 2022, codice identificativo 2022AA37N3
  • The Next Generation EU - project Tech4You - Technologies for climate change adaptation and quality of life improvement, n. ECS0000009
  • co-funding from Next Generation EU, in the context of the National Recovery and Resilience Plan, Investment PE8-Project Age-It: "Ageing Well in an Ageing Socie…

Zitieren

APA

De Bartolo, A., Romeo, N., Angelone, T., & Rocca, C. (2025). Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential. Acta Physiologica, 241(7). https://doi.org/10.1111/apha.70062

Vancouver

De Bartolo A, Romeo N, Angelone T, Rocca C. Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential. Acta Physiologica. 2025;241(7). doi:10.1111/apha.70062

BibTeX
@article{DeBartolo2025,
  author = {De Bartolo, Anna and Romeo, Naomi and Angelone, Tommaso and Rocca, Carmine},
  title = {Specialized Pro‐Resolving Mediators as Emerging Players in Cardioprotection: From Inflammation Resolution to Therapeutic Potential},
  journal = {Acta Physiologica},
  year = {2025},
  volume = {241},
  number = {7},
  doi = {10.1111/apha.70062}
}
Kostenlos starten →